Department of Periodontology, Research Institute for Periodontal Regeneration, College of Dentistry, Yonsei University, Seoul, Korea.
J Periodontal Res. 2012 Oct;47(5):645-54. doi: 10.1111/j.1600-0765.2012.01477.x. Epub 2012 Apr 4.
Recombinant human bone morphogenetic protein-2 (rhBMP-2) is a well-known growth factor that can induce robust bone formation, and recent studies have shown that rhBMP-2-induced osteogenesis is closely related to adipogenesis. The aim of the present study was to determine the dose- and time-dependent effects of rhBMP-2 on the osteogenic and adipogenic differentiation of human alveolar bone-derived stromal cells (hABCs) in vivo and in vitro.
hABCs were isolated and cultured, and then transplanted using a carrier treated either with or without rhBMP-2 (100 μg/mL) into an ectopic subcutaneous mouse model. Comprehensive histologic and histometric analyses were performed after an 8-wk healing period. To further understand the dose-dependent (0, 10, 50, 200, 500 and 1000 ng/mL) and time-dependent (0, 3, 5, 7 and 14 d) effects of rhBMP-2 on osteogenic and adipogenic differentiation, in vitro osteogenic and adipogenic differentiation of hABCs were evaluated, and the expression of related mRNAs, including those for alkaline phosphatase, osteocalcin, bone sialoprotein, peroxisome-proliferator-activated receptor gamma-2 and lipoprotein lipase, were assessed using quantitative RT-PCR.
rhBMP-2 significantly promoted the osteogenic and adipogenic differentiation of hABCs in vivo, and gradually increased both the osteogenic and adipogenic potential in a dose- and time-dependent manner with minimal deviation in vitro. The expression of osteogenesis- and adipogenesis-associated mRNAs were concomitantly up-regulated by rhBMP-2.
The findings of the present study showed that rhBMP-2 significantly enhanced the adipogenic as well as the osteogenic potential of hABCs in dose- and time-dependent manner. The control of adipogenic differentiation of hABCs should be considered when regenerating the alveolar bone using rhBMP-2.
重组人骨形态发生蛋白-2(rhBMP-2)是一种众所周知的生长因子,可诱导强劲的骨形成,最近的研究表明,rhBMP-2 诱导的成骨作用与脂肪生成密切相关。本研究旨在确定 rhBMP-2 对体内和体外人牙槽骨基质细胞(hABC)成骨和成脂分化的剂量和时间依赖性影响。
分离和培养 hABC,然后使用载体制备物将其移植到异位皮下小鼠模型中,该载体制备物经过或未经 rhBMP-2(100 μg/mL)处理。在 8 周的愈合期后进行综合组织学和组织计量学分析。为了进一步了解 rhBMP-2 对成骨和成脂分化的剂量依赖性(0、10、50、200、500 和 1000 ng/mL)和时间依赖性(0、3、5、7 和 14 d)影响,评估了 hABC 的体外成骨和成脂分化,并使用定量 RT-PCR 评估相关 mRNA 的表达,包括碱性磷酸酶、骨钙素、骨涎蛋白、过氧化物酶体增殖物激活受体 γ-2 和脂蛋白脂肪酶。
rhBMP-2 显著促进了 hABC 的体内成骨和成脂分化,并逐渐增加了成骨和成脂潜能,呈剂量和时间依赖性,体外最小偏差。rhBMP-2 同时上调了与成骨和成脂相关的 mRNA 的表达。
本研究结果表明,rhBMP-2 显著增强了 hABC 的成脂和成骨潜能,呈剂量和时间依赖性。在使用 rhBMP-2 再生牙槽骨时,应考虑控制 hABC 的脂肪分化。